Astellas for AAV vectors directed to skeletal and cardical muscle
Roche & Spark for AAV vectors directed to CNS and liver
Sarepta for next-gen gene therapy vectors for muscle disease
Dyno Therapeutics to Accelerate Design of High-Performance Biological Sequences Using NVIDIA AI
Dyno Therapeutics Unveils Path to Exponentially Reducing the Cost of In Vivo Gene Delivery at the 2024 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
2023 & 2022 FORBES LIST: AMERICA’S BEST STARTUP EMPLOYEER For the second year in a row, Dyno is recognized on the Forbes list of America’s Best Startup Employers
NEVY AWARDS Dyno named Emerging Company of the Year by the New England Venture Capital Association
ENDPOINTS NEWS Dyno named one of the most promising startups of 2021